View Exam | PowerPak

1. In the American Association for the Study of Liver Diseases guideline, a Metavir score of F4 describes:

A. Mild fibrosis B. Advanced fibrosis C. Compensated cirrhosis D. Hepatocellular carcinoma

2. Compared with patients without cirrhosis, antiviral treatment recommendations for patients with chronic hepatitis C virus infection and cirrhosis are generally characterized by:

A. A longer treatment duration B. A higher target antiviral dosing C. Precautions against concomitant ribavirin use D. More precautions regarding other drug-drug interactions

3. KP is a 56-year-old woman with hepatitis C virus (HCV) genotype 1 infection who is unable to undergo further HCV genotype or subtype testing. Which of the following sets of treatment recommendations represents the BEST course of management for KP?

A. Nongenotype-specific treatment recommendations B. HCV genotype 1 treatment recommendations C. HCV genotype 1a treatment recommendations D. HCV genotype 1b treatment recommendations

4. Which of the following significantly predicts a higher baseline hepatitis C virus (HCV) RNA viral load?

A. A patient who is 65 years of age or older B. A patient with HCV genotype 2 infection C. A patient with HCV genotype 3 infection D. A patient with HIV coinfection

5. SE is a 64-year-old man with noncirrhotic, treatment-naïve, hepatitis C virus (HCV) genotype 1 infection. Baseline testing showed an HCV RNA level of 4.3 million IU/mL. Which of the following treatment regimens would be MOST appropriate for SE?

A. Ledipasvir/sofosbuvir therapy for 8 weeks B. Ledipasvir/sofosbuvir therapy for 12 weeks C. Ledipasvir/sofosbuvir plus RBV therapy for 8 weeks D. Ledipasvir/sofosbuvir plus RBV therapy for 12 weeks

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. In the American Association for the Study of Liver Diseases guideline, a Metavir score of F4 describes:

2. Compared with patients without cirrhosis, antiviral treatment recommendations for patients with chronic hepatitis C virus infection and cirrhosis are generally characterized by:

3. KP is a 56-year-old woman with hepatitis C virus (HCV) genotype 1 infection who is unable to undergo further HCV genotype or subtype testing. Which of the following sets of treatment recommendations represents the BEST course of management for KP?

4. Which of the following significantly predicts a higher baseline hepatitis C virus (HCV) RNA viral load?

5. SE is a 64-year-old man with noncirrhotic, treatment-naïve, hepatitis C virus (HCV) genotype 1 infection. Baseline testing showed an HCV RNA level of 4.3 million IU/mL. Which of the following treatment regimens would be MOST appropriate for SE?

« Return to Activity

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. In the American Association for the Study of Liver Diseases guideline, a Metavir score of F4 describes:

2. Compared with patients without cirrhosis, antiviral treatment recommendations for patients with chronic hepatitis C virus infection and cirrhosis are generally characterized by:

3. KP is a 56-year-old woman with hepatitis C virus (HCV) genotype 1 infection who is unable to undergo further HCV genotype or subtype testing. Which of the following sets of treatment recommendations represents the BEST course of management for KP?

4. Which of the following significantly predicts a higher baseline hepatitis C virus (HCV) RNA viral load?

5. SE is a 64-year-old man with noncirrhotic, treatment-naïve, hepatitis C virus (HCV) genotype 1 infection. Baseline testing showed an HCV RNA level of 4.3 million IU/mL. Which of the following treatment regimens would be MOST appropriate for SE?

« Return to Activity

Customers who Purchased
this Activity also Purchased